Zentalis Pharmaceuticals Inc (ZNTL)
11.71
+0.60
(+5.40%)
USD |
NASDAQ |
May 03, 16:00
11.71
0.00 (0.00%)
After-Hours: 20:00
Zentalis Pharmaceuticals Free Cash Flow: -208.40M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -208.40M |
| September 30, 2023 | -205.12M |
| June 30, 2023 | -201.22M |
| March 31, 2023 | -164.94M |
| December 31, 2022 | -166.30M |
| September 30, 2022 | -168.02M |
| June 30, 2022 | -169.31M |
| March 31, 2022 | -172.94M |
| December 31, 2021 | -160.20M |
| Date | Value |
|---|---|
| September 30, 2021 | -149.01M |
| June 30, 2021 | -133.46M |
| March 31, 2021 | -108.59M |
| December 31, 2020 | -87.58M |
| September 30, 2020 | -72.79M |
| June 30, 2020 | -62.28M |
| March 31, 2020 | -47.35M |
| December 31, 2019 | -39.50M |
Free Cash Flow Range, Past 5 Years
-208.40M
Minimum
Dec 2023
-39.50M
Maximum
Dec 2019
-136.30M
Average
-160.20M
Median
Dec 2021
Free Cash Flow Benchmarks
| Revolution Medicines Inc | -358.30M |
| Day One Biopharmaceuticals Inc | -150.08M |
| Perspective Therapeutics Inc | -37.98M |
| Electromed Inc | 3.653M |
| Xtant Medical Holdings Inc | -10.97M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -40.60M |
| Cash from Investing (Quarterly) | -42.06M |
| Free Cash Flow Per Share (Quarterly) | -0.5756 |
| Free Cash Flow Yield | -27.22% |